Slovenia's KRKA to open new zl.100 million Warsaw medicines factory

As part of a regional expansion program, Slovenian pharmaceuticals company KRKA is to open a new production plant in Warsaw. The plant, which has been built at a cost of over zl.100 million, will be in operation by the end of October. According to KRKA Polska CEO Jozef Kolaric, the plant will produce four medicines, in the form of tablets and capsules. Kolaric added that KRKA plans over the next six years to increase its market share in Poland from the current 1.8%, to 2.5%. Through a policy of gradually introducing medicines on to the Polish market, the company expects to increase its revenues to as much as zl.180 million this year, from zl.166 million last year. Following the opening of its Warsaw plant, KRKA will in the next eighteen months begin operations at two other plants, one in Moscow and the other in Zagreb. (Puls Biznesu, p. 9) M.T.